Barriers and facilitators of prevention of infections related to cancer: A systematic literature review
Chronic infections such as Helicobacter pylori (Hp), Hepatitis B virus (HBV), Hepatitis C virus (HCV), and Human papillomavirus (HPV) are a major cause of gastric, liver, and HPV-related cancers that contribute significantly to the global burden of human cancers. Infections related to cancers can be...
Gespeichert in:
Veröffentlicht in: | Heliyon 2024-10, Vol.10 (19), p.e37959, Article e37959 |
---|---|
Hauptverfasser: | , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | |
---|---|
container_issue | 19 |
container_start_page | e37959 |
container_title | Heliyon |
container_volume | 10 |
creator | Ragelienė, Tija Schneider-Kamp, Anna Askegaard, Søren Tollestrup |
description | Chronic infections such as Helicobacter pylori (Hp), Hepatitis B virus (HBV), Hepatitis C virus (HCV), and Human papillomavirus (HPV) are a major cause of gastric, liver, and HPV-related cancers that contribute significantly to the global burden of human cancers. Infections related to cancers can be prevented by preventing infection through vaccination, timely detection through screening, and eradication of the underlying infections. These strategies have proven effective in different countries, but the participation rates of vaccination, screening, and eradication programs for Hp, HCV, and HPV are less than optimal. Research has shown that participation rates are influenced by various social, cultural, economic, and personal barriers and facilitators. To uncover the current evidence and enhance the understanding of the factors of prevention of infections related to cancer, we conducted a systematic literature review of such barriers and facilitators. We searched Web of Science, PubMed, and Scopus databases to identify relevant original articles published between 2013 and 2023. After screening 685 articles, a total of 23 studies were included for full-text analysis. Most of the studies analyzed factors related to the prevention of HBV, HPV, and HCV infections, while there was a relative lack of studies for Hp infections. Vaccination as a prevention measure of infections related to cancer was analyzed in most of the studies, followed by screening and treatment. We found several personal, social, economic, and cultural factors that act as barriers to the prevention of infections related to cancer and classified and connected these barriers and facilitators through the prism of health capital. Knowledge about the barriers that influence individuals’ engagement with prevention measures of infections related to cancer has the potential to inform and guide health policymakers by targeting vulnerable populations through effective educational programs and improvements to the quality of healthcare services.
•Chronic infections such as Hp, HBV, HCV, and HPV are a major cause of gastric, liver, and HPV-related cancers that contribute significantly to the global burden of human cancers.•Infections related to cancers can be prevented by preventing infection through vaccination, timely detection through screening, and eradication of the underlying infections.•To uncover the current evidence and enhance the understanding of the factors of prevention of infections related |
doi_str_mv | 10.1016/j.heliyon.2024.e37959 |
format | Article |
fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_11462020</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S2405844024139904</els_id><sourcerecordid>3154172154</sourcerecordid><originalsourceid>FETCH-LOGICAL-c2949-e3c6938e7d1141e9a7797d5e5a4d2a361f516b28e964a33e991c32668bec82dd3</originalsourceid><addsrcrecordid>eNqNUU1vEzEQtRCIVqU_AeQjlwR_75oLKlVbkCr1AmdrYs-2jjbrYDtB-fc4SlrKiV5sz_jNm5n3CHnP2Zwzbj4t5w84xl2a5oIJNUfZWW1fkVOhmJ71SrHXz94n5LyUJWOM697YTr4lJ9LK3vSanZL7r5BzxFwoTIEO4OMYK9TUEmmg64xbnGpM0z6K04B-HxSacYSKgdZEPUwe82d6QcuuVFxBjZ42EsxQNxkbdBvx9zvyZoCx4PnxPiM_r69-XH6b3d7dfL-8uJ15YZWdofSmzYZd4FxxtNB1tgsaNaggQBo-aG4WokdrFEiJ1nIvhTH9An0vQpBn5MuBd71ZrDD4Nn2G0a1zXEHeuQTR_fszxQd3n7au9TNNTNYYPh4Zcvq1wVLdKhaP4wgTpk1xkmvFO9HOF0C5ZrZp3jWoPkB9TqVkHJ5G4sztPXVLd_TU7T11B09b3Yfn-zxVPTr4d2Fsqjalsys-YrMkxNzcciHF_7T4A1Kkt5g</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>3115096977</pqid></control><display><type>article</type><title>Barriers and facilitators of prevention of infections related to cancer: A systematic literature review</title><source>DOAJ Directory of Open Access Journals</source><source>PubMed Central</source><source>Alma/SFX Local Collection</source><source>EZB Electronic Journals Library</source><creator>Ragelienė, Tija ; Schneider-Kamp, Anna ; Askegaard, Søren Tollestrup</creator><creatorcontrib>Ragelienė, Tija ; Schneider-Kamp, Anna ; Askegaard, Søren Tollestrup</creatorcontrib><description>Chronic infections such as Helicobacter pylori (Hp), Hepatitis B virus (HBV), Hepatitis C virus (HCV), and Human papillomavirus (HPV) are a major cause of gastric, liver, and HPV-related cancers that contribute significantly to the global burden of human cancers. Infections related to cancers can be prevented by preventing infection through vaccination, timely detection through screening, and eradication of the underlying infections. These strategies have proven effective in different countries, but the participation rates of vaccination, screening, and eradication programs for Hp, HCV, and HPV are less than optimal. Research has shown that participation rates are influenced by various social, cultural, economic, and personal barriers and facilitators. To uncover the current evidence and enhance the understanding of the factors of prevention of infections related to cancer, we conducted a systematic literature review of such barriers and facilitators. We searched Web of Science, PubMed, and Scopus databases to identify relevant original articles published between 2013 and 2023. After screening 685 articles, a total of 23 studies were included for full-text analysis. Most of the studies analyzed factors related to the prevention of HBV, HPV, and HCV infections, while there was a relative lack of studies for Hp infections. Vaccination as a prevention measure of infections related to cancer was analyzed in most of the studies, followed by screening and treatment. We found several personal, social, economic, and cultural factors that act as barriers to the prevention of infections related to cancer and classified and connected these barriers and facilitators through the prism of health capital. Knowledge about the barriers that influence individuals’ engagement with prevention measures of infections related to cancer has the potential to inform and guide health policymakers by targeting vulnerable populations through effective educational programs and improvements to the quality of healthcare services.
•Chronic infections such as Hp, HBV, HCV, and HPV are a major cause of gastric, liver, and HPV-related cancers that contribute significantly to the global burden of human cancers.•Infections related to cancers can be prevented by preventing infection through vaccination, timely detection through screening, and eradication of the underlying infections.•To uncover the current evidence and enhance the understanding of the factors of prevention of infections related to cancer, we conducted a systematic literature review of barriers and facilitators.•Vaccination as a prevention measure of infections related to cancer was analyzed in most of the studies, followed by screening and treatment.•We found several personal, social, economic, and cultural factors that act as barriers to the prevention of infections related to cancer and classified and connected these barriers and facilitators through the prism of health capital.</description><identifier>ISSN: 2405-8440</identifier><identifier>EISSN: 2405-8440</identifier><identifier>DOI: 10.1016/j.heliyon.2024.e37959</identifier><identifier>PMID: 39386850</identifier><language>eng</language><publisher>England: Elsevier Ltd</publisher><subject>capital ; health services ; Helicobacter pylori ; Hepatitis B virus ; Hepatitis C virus ; humans ; liver ; Papillomaviridae ; vaccination</subject><ispartof>Heliyon, 2024-10, Vol.10 (19), p.e37959, Article e37959</ispartof><rights>2024 The Authors</rights><rights>2024 The Authors.</rights><rights>2024 The Authors 2024</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c2949-e3c6938e7d1141e9a7797d5e5a4d2a361f516b28e964a33e991c32668bec82dd3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC11462020/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC11462020/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,723,776,780,860,881,27901,27902,53766,53768</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/39386850$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Ragelienė, Tija</creatorcontrib><creatorcontrib>Schneider-Kamp, Anna</creatorcontrib><creatorcontrib>Askegaard, Søren Tollestrup</creatorcontrib><title>Barriers and facilitators of prevention of infections related to cancer: A systematic literature review</title><title>Heliyon</title><addtitle>Heliyon</addtitle><description>Chronic infections such as Helicobacter pylori (Hp), Hepatitis B virus (HBV), Hepatitis C virus (HCV), and Human papillomavirus (HPV) are a major cause of gastric, liver, and HPV-related cancers that contribute significantly to the global burden of human cancers. Infections related to cancers can be prevented by preventing infection through vaccination, timely detection through screening, and eradication of the underlying infections. These strategies have proven effective in different countries, but the participation rates of vaccination, screening, and eradication programs for Hp, HCV, and HPV are less than optimal. Research has shown that participation rates are influenced by various social, cultural, economic, and personal barriers and facilitators. To uncover the current evidence and enhance the understanding of the factors of prevention of infections related to cancer, we conducted a systematic literature review of such barriers and facilitators. We searched Web of Science, PubMed, and Scopus databases to identify relevant original articles published between 2013 and 2023. After screening 685 articles, a total of 23 studies were included for full-text analysis. Most of the studies analyzed factors related to the prevention of HBV, HPV, and HCV infections, while there was a relative lack of studies for Hp infections. Vaccination as a prevention measure of infections related to cancer was analyzed in most of the studies, followed by screening and treatment. We found several personal, social, economic, and cultural factors that act as barriers to the prevention of infections related to cancer and classified and connected these barriers and facilitators through the prism of health capital. Knowledge about the barriers that influence individuals’ engagement with prevention measures of infections related to cancer has the potential to inform and guide health policymakers by targeting vulnerable populations through effective educational programs and improvements to the quality of healthcare services.
•Chronic infections such as Hp, HBV, HCV, and HPV are a major cause of gastric, liver, and HPV-related cancers that contribute significantly to the global burden of human cancers.•Infections related to cancers can be prevented by preventing infection through vaccination, timely detection through screening, and eradication of the underlying infections.•To uncover the current evidence and enhance the understanding of the factors of prevention of infections related to cancer, we conducted a systematic literature review of barriers and facilitators.•Vaccination as a prevention measure of infections related to cancer was analyzed in most of the studies, followed by screening and treatment.•We found several personal, social, economic, and cultural factors that act as barriers to the prevention of infections related to cancer and classified and connected these barriers and facilitators through the prism of health capital.</description><subject>capital</subject><subject>health services</subject><subject>Helicobacter pylori</subject><subject>Hepatitis B virus</subject><subject>Hepatitis C virus</subject><subject>humans</subject><subject>liver</subject><subject>Papillomaviridae</subject><subject>vaccination</subject><issn>2405-8440</issn><issn>2405-8440</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2024</creationdate><recordtype>article</recordtype><recordid>eNqNUU1vEzEQtRCIVqU_AeQjlwR_75oLKlVbkCr1AmdrYs-2jjbrYDtB-fc4SlrKiV5sz_jNm5n3CHnP2Zwzbj4t5w84xl2a5oIJNUfZWW1fkVOhmJ71SrHXz94n5LyUJWOM697YTr4lJ9LK3vSanZL7r5BzxFwoTIEO4OMYK9TUEmmg64xbnGpM0z6K04B-HxSacYSKgdZEPUwe82d6QcuuVFxBjZ42EsxQNxkbdBvx9zvyZoCx4PnxPiM_r69-XH6b3d7dfL-8uJ15YZWdofSmzYZd4FxxtNB1tgsaNaggQBo-aG4WokdrFEiJ1nIvhTH9An0vQpBn5MuBd71ZrDD4Nn2G0a1zXEHeuQTR_fszxQd3n7au9TNNTNYYPh4Zcvq1wVLdKhaP4wgTpk1xkmvFO9HOF0C5ZrZp3jWoPkB9TqVkHJ5G4sztPXVLd_TU7T11B09b3Yfn-zxVPTr4d2Fsqjalsys-YrMkxNzcciHF_7T4A1Kkt5g</recordid><startdate>20241015</startdate><enddate>20241015</enddate><creator>Ragelienė, Tija</creator><creator>Schneider-Kamp, Anna</creator><creator>Askegaard, Søren Tollestrup</creator><general>Elsevier Ltd</general><general>Elsevier</general><scope>6I.</scope><scope>AAFTH</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>7S9</scope><scope>L.6</scope><scope>5PM</scope></search><sort><creationdate>20241015</creationdate><title>Barriers and facilitators of prevention of infections related to cancer: A systematic literature review</title><author>Ragelienė, Tija ; Schneider-Kamp, Anna ; Askegaard, Søren Tollestrup</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c2949-e3c6938e7d1141e9a7797d5e5a4d2a361f516b28e964a33e991c32668bec82dd3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2024</creationdate><topic>capital</topic><topic>health services</topic><topic>Helicobacter pylori</topic><topic>Hepatitis B virus</topic><topic>Hepatitis C virus</topic><topic>humans</topic><topic>liver</topic><topic>Papillomaviridae</topic><topic>vaccination</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Ragelienė, Tija</creatorcontrib><creatorcontrib>Schneider-Kamp, Anna</creatorcontrib><creatorcontrib>Askegaard, Søren Tollestrup</creatorcontrib><collection>ScienceDirect Open Access Titles</collection><collection>Elsevier:ScienceDirect:Open Access</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>AGRICOLA</collection><collection>AGRICOLA - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Heliyon</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Ragelienė, Tija</au><au>Schneider-Kamp, Anna</au><au>Askegaard, Søren Tollestrup</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Barriers and facilitators of prevention of infections related to cancer: A systematic literature review</atitle><jtitle>Heliyon</jtitle><addtitle>Heliyon</addtitle><date>2024-10-15</date><risdate>2024</risdate><volume>10</volume><issue>19</issue><spage>e37959</spage><pages>e37959-</pages><artnum>e37959</artnum><issn>2405-8440</issn><eissn>2405-8440</eissn><abstract>Chronic infections such as Helicobacter pylori (Hp), Hepatitis B virus (HBV), Hepatitis C virus (HCV), and Human papillomavirus (HPV) are a major cause of gastric, liver, and HPV-related cancers that contribute significantly to the global burden of human cancers. Infections related to cancers can be prevented by preventing infection through vaccination, timely detection through screening, and eradication of the underlying infections. These strategies have proven effective in different countries, but the participation rates of vaccination, screening, and eradication programs for Hp, HCV, and HPV are less than optimal. Research has shown that participation rates are influenced by various social, cultural, economic, and personal barriers and facilitators. To uncover the current evidence and enhance the understanding of the factors of prevention of infections related to cancer, we conducted a systematic literature review of such barriers and facilitators. We searched Web of Science, PubMed, and Scopus databases to identify relevant original articles published between 2013 and 2023. After screening 685 articles, a total of 23 studies were included for full-text analysis. Most of the studies analyzed factors related to the prevention of HBV, HPV, and HCV infections, while there was a relative lack of studies for Hp infections. Vaccination as a prevention measure of infections related to cancer was analyzed in most of the studies, followed by screening and treatment. We found several personal, social, economic, and cultural factors that act as barriers to the prevention of infections related to cancer and classified and connected these barriers and facilitators through the prism of health capital. Knowledge about the barriers that influence individuals’ engagement with prevention measures of infections related to cancer has the potential to inform and guide health policymakers by targeting vulnerable populations through effective educational programs and improvements to the quality of healthcare services.
•Chronic infections such as Hp, HBV, HCV, and HPV are a major cause of gastric, liver, and HPV-related cancers that contribute significantly to the global burden of human cancers.•Infections related to cancers can be prevented by preventing infection through vaccination, timely detection through screening, and eradication of the underlying infections.•To uncover the current evidence and enhance the understanding of the factors of prevention of infections related to cancer, we conducted a systematic literature review of barriers and facilitators.•Vaccination as a prevention measure of infections related to cancer was analyzed in most of the studies, followed by screening and treatment.•We found several personal, social, economic, and cultural factors that act as barriers to the prevention of infections related to cancer and classified and connected these barriers and facilitators through the prism of health capital.</abstract><cop>England</cop><pub>Elsevier Ltd</pub><pmid>39386850</pmid><doi>10.1016/j.heliyon.2024.e37959</doi><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 2405-8440 |
ispartof | Heliyon, 2024-10, Vol.10 (19), p.e37959, Article e37959 |
issn | 2405-8440 2405-8440 |
language | eng |
recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_11462020 |
source | DOAJ Directory of Open Access Journals; PubMed Central; Alma/SFX Local Collection; EZB Electronic Journals Library |
subjects | capital health services Helicobacter pylori Hepatitis B virus Hepatitis C virus humans liver Papillomaviridae vaccination |
title | Barriers and facilitators of prevention of infections related to cancer: A systematic literature review |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-01T08%3A17%3A09IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Barriers%20and%20facilitators%20of%20prevention%20of%20infections%20related%20to%20cancer:%20A%20systematic%20literature%20review&rft.jtitle=Heliyon&rft.au=Ragelien%C4%97,%20Tija&rft.date=2024-10-15&rft.volume=10&rft.issue=19&rft.spage=e37959&rft.pages=e37959-&rft.artnum=e37959&rft.issn=2405-8440&rft.eissn=2405-8440&rft_id=info:doi/10.1016/j.heliyon.2024.e37959&rft_dat=%3Cproquest_pubme%3E3154172154%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=3115096977&rft_id=info:pmid/39386850&rft_els_id=S2405844024139904&rfr_iscdi=true |